Haemonetics
HAE
#3028
Rank
A$7.63 B
Marketcap
A$167.70
Share price
-2.09%
Change (1 day)
115.84%
Change (1 year)

Haemonetics (HAE) - P/B ratio

P/B ratio as of October 2026 : 6.36

According to Haemonetics's latest financial reports the company has a price-to-book ratio of 3.93628.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Haemonetics - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-314.23-1.59%
2024-12-314.30-6.6%
2023-12-314.60-10.33%
2022-12-315.1338.29%
2021-12-313.71-55.76%
2020-12-318.38-16.79%
2019-12-3110.127.03%
2018-12-317.93112.77%
2017-12-313.7338.4%
2016-12-312.6918.35%
2015-12-312.28-1.49%
2014-12-312.31-12.78%
2013-12-312.65-2.13%
2012-12-312.7124.81%
2011-12-312.17-10.05%
2010-12-312.41-0.28%
2009-12-312.42-13.21%
2008-12-312.79-18.27%
2007-12-313.4129.93%
2006-12-312.62-15.43%
2005-12-313.1011.18%
2004-12-312.7923.95%
2003-12-312.25-4.25%
2002-12-312.35

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.40 16.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.22-65.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
4.63-27.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
2.04-67.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.04-67.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
4.44-30.19%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
1.80-71.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
6.53 2.65%๐Ÿ‡บ๐Ÿ‡ธ USA